enVVeno Medical
NVNO
36 hedge funds and large institutions have $5.4M invested in enVVeno Medical in 2025 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 12 closing their positions.
850% more call options, than puts
Call options by funds: $114K | Put options by funds: $12K
140% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 5
0.06% more ownership
Funds ownership: 0.83% → 0.89% (+0.06%)
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
3% less funds holding
Funds holding: 37 → 36 (-1)
73% less capital invested
Capital invested by funds: $20.3M → $5.4M (-$14.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
CM Management
Gulf Breeze,
Florida
|
+$1.75M |
| 2 |
KCM
Kingdon Capital Management
New York
|
+$1.46M |
| 3 |
PA
Perceptive Advisors
New York
|
+$1.38M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$475K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$451K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$2.37M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$962K |
| 3 |
Universal-Beteiligungs- und Servicegesellschaft
Frankfurt Am Main,
Germany
|
-$798K |
| 4 |
RFC
Regions Financial Corp
Birmingham,
Alabama
|
-$273K |
| 5 |
Morgan Stanley
New York
|
-$209K |
NVNO Hedge Fund Activity: Q3 2025 in Review
36 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q3 2025, worth a combined $5.4M — down 73% from $20.3M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of NVNO and 11 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 12 added.
The largest buyer was CM Management, opening a new position worth an estimated $1.75M. The largest seller was Nantahala Capital Management, exiting entirely with an estimated $2.37M sold.
- 36 institutional investors held enVVeno Medical (NVNO) as of Q3 2025, down from 37 in Q2 2025.
- Funds reported $5.4M of enVVeno Medical stock for Q3 2025, down 73% quarter-over-quarter.
- 11 funds opened new enVVeno Medical positions in Q3 2025 and 12 closed out, a net change of -1 holder.
- The largest enVVeno Medical buyer in Q3 2025 was CM Management, an estimated $1.75M added.
- The largest enVVeno Medical seller in Q3 2025 was Nantahala Capital Management, an estimated $2.37M sold.
Based on aggregated 13F filings for Q3 2025.